JP2014527040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527040A5 JP2014527040A5 JP2014521801A JP2014521801A JP2014527040A5 JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5 JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutical composition
- seq
- composition according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509340P | 2011-07-19 | 2011-07-19 | |
| US61/509,340 | 2011-07-19 | ||
| US201261662337P | 2012-06-20 | 2012-06-20 | |
| US61/662,337 | 2012-06-20 | ||
| PCT/US2012/047468 WO2013013085A2 (en) | 2011-07-19 | 2012-07-19 | Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014527040A JP2014527040A (ja) | 2014-10-09 |
| JP2014527040A5 true JP2014527040A5 (https=) | 2015-08-20 |
Family
ID=47558730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521801A Pending JP2014527040A (ja) | 2011-07-19 | 2012-07-19 | 抗−線維化ペプチド並びに線維化を特徴とする疾患及び障害を治療するための方法における該抗−線維化ペプチドの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140057831A1 (https=) |
| EP (1) | EP2734220A4 (https=) |
| JP (1) | JP2014527040A (https=) |
| CN (2) | CN106478776A (https=) |
| AU (1) | AU2012283924A1 (https=) |
| BR (1) | BR112014001268A2 (https=) |
| CA (1) | CA2842330A1 (https=) |
| HK (1) | HK1198333A1 (https=) |
| IL (1) | IL230510A0 (https=) |
| RU (1) | RU2014105513A (https=) |
| WO (1) | WO2013013085A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170232276A1 (en) * | 2014-09-30 | 2017-08-17 | Primegen Biotech, Llc | Treatment of fibrosis using deep tissue heating and stem cell therapy |
| WO2016077539A1 (en) * | 2014-11-12 | 2016-05-19 | Thrasos Innovation, Inc. | Peptides with enhanced stability and their use in methods for treating diseases |
| EP3289073A4 (en) * | 2015-05-01 | 2019-07-17 | University of Miami | METHOD AND COMPOSITIONS FOR THE CONVERSION OF NON-ENDOCRINE PANCREATIC TISSUE IN INSULIN-PRODUCING CELLS |
| AU2016260190A1 (en) * | 2015-05-12 | 2017-11-23 | The Regents Of The University Of California | Peptide treatment for inflammation and fibrosis |
| CN115925878A (zh) * | 2015-06-05 | 2023-04-07 | 艾比欧公司 | 用于治疗纤维化的内皮抑素片段和变体 |
| WO2019133950A1 (en) * | 2017-12-30 | 2019-07-04 | The Regents Of The University Of Colorado, A Body Corporate | Smad7 for treatment and prevention of posterior capsule opacification |
| ES2906715T3 (es) * | 2018-09-06 | 2022-04-20 | Marine Essence Biosciences Corp Of Usa | Dispositivos de biomaterial para la regeneración de tejidos guiada |
| US11361161B2 (en) * | 2018-10-22 | 2022-06-14 | Verint Americas Inc. | Automated system and method to prioritize language model and ontology expansion and pruning |
| EP3996736A4 (en) * | 2019-07-10 | 2023-05-24 | Musc Foundation for Research Development | ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMOR, FIBROSIS AND ACUTE LUNG INJURY |
| CN111704653B (zh) * | 2020-06-08 | 2023-10-03 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
| CA3212468A1 (en) * | 2021-03-16 | 2022-09-22 | William D. Carlson | Therapeutic combinations of tdfrps and additional agents and methods of use for the reversal of fibrosis |
| CN113069531B (zh) * | 2021-04-09 | 2023-02-28 | 南开大学 | 一种防疤痕皮肤创伤修复用水凝胶及其制备方法 |
| CN116768974A (zh) * | 2022-03-11 | 2023-09-19 | 中山大学 | 用于预防和/或治疗肾纤维化的多肽化合物 |
| WO2024081245A1 (en) | 2022-10-10 | 2024-04-18 | Therapeutics By Design, LLC | Tissue differentiation factor related polypeptides (tdfrps) for the treatment of myocardial injury |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0894004B2 (en) * | 1996-03-22 | 2007-02-21 | Curis, Inc. | Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| WO2003106656A2 (en) * | 2002-06-17 | 2003-12-24 | Thrasos, Inc. | Single domain tdf-related compounds and analogs thereof |
| US8410246B2 (en) * | 2004-06-17 | 2013-04-02 | Thrasos, Inc. | TDF-related compounds and analogs thereof |
| DK2497780T3 (en) * | 2005-09-20 | 2015-06-01 | Thrasos Innovation Inc | TDF-related compounds and analogs thereof |
| US20110275574A1 (en) * | 2009-01-16 | 2011-11-10 | Agency For Science, Technology And Research | Method of inhibiting proliferation of hepatic stellate cells |
| WO2010099363A1 (en) * | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| WO2010128158A1 (en) * | 2009-05-08 | 2010-11-11 | Novartis Ag | Diagnostic biomarkers for fibrotic disorders |
-
2012
- 2012-07-19 HK HK14111848.5A patent/HK1198333A1/zh unknown
- 2012-07-19 CN CN201610543024.0A patent/CN106478776A/zh active Pending
- 2012-07-19 WO PCT/US2012/047468 patent/WO2013013085A2/en not_active Ceased
- 2012-07-19 US US13/553,685 patent/US20140057831A1/en not_active Abandoned
- 2012-07-19 EP EP12814119.9A patent/EP2734220A4/en not_active Withdrawn
- 2012-07-19 CA CA2842330A patent/CA2842330A1/en not_active Abandoned
- 2012-07-19 AU AU2012283924A patent/AU2012283924A1/en not_active Abandoned
- 2012-07-19 RU RU2014105513/04A patent/RU2014105513A/ru not_active Application Discontinuation
- 2012-07-19 CN CN201280045650.7A patent/CN103890003B/zh not_active Expired - Fee Related
- 2012-07-19 BR BR112014001268A patent/BR112014001268A2/pt not_active IP Right Cessation
- 2012-07-19 JP JP2014521801A patent/JP2014527040A/ja active Pending
-
2014
- 2014-01-16 IL IL230510A patent/IL230510A0/en unknown
-
2015
- 2015-08-05 US US14/818,652 patent/US20160058829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527040A5 (https=) | ||
| RU2014105513A (ru) | Противофиброзные пептиды и их применение в способах лечения заболеваний и расстройств, характеризующихся фиброзом | |
| JP2015517488A5 (https=) | ||
| HRP20200889T1 (hr) | Upotreba dugodjelujućih peptida glp-1 | |
| JP2015517489A5 (https=) | ||
| JP2015518818A5 (https=) | ||
| JP2014508753A5 (https=) | ||
| JP2015057436A5 (https=) | ||
| JP2012092110A5 (https=) | ||
| JP2011528332A5 (https=) | ||
| HRP20180425T1 (hr) | Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline | |
| MX2018015315A (es) | Agentes antivirales contra la hepatitis b. | |
| EA201491245A1 (ru) | Новые дигидропиримидинизохинолиноны и содержащие их фармацевтические композиции для лечения воспалительных нарушений | |
| JP2013542247A5 (https=) | ||
| JP2013505205A5 (https=) | ||
| JP2012144574A5 (https=) | ||
| NZ708501A (en) | Treatment of pulmonary disease | |
| JP2013509429A5 (https=) | ||
| JP2015513318A5 (https=) | ||
| JP2016534153A5 (https=) | ||
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| JP2015533791A5 (https=) | ||
| JP2014529399A5 (https=) | ||
| MX2014013851A (es) | Composiciones farmaceuticas topicas que comprenden terbinafina y urea. |